Protein,Protein_definition,Disease_category,Disease,Method,Nb_SNP,OR[95%CI],P_value
MFAP5,Microfibrillar-associated protein 5,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,Inverse variance weighted,2,1.23 [0.99-1.52],0.0565057875792562
MFAP5,Microfibrillar-associated protein 5,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,Inverse variance weighted,2,1.23 [1.03-1.48],0.0236437324648436
MFAP5,Microfibrillar-associated protein 5,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",Inverse variance weighted,2,1.15 [0.79-1.67],0.465043871150281
MFAP5,Microfibrillar-associated protein 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,Inverse variance weighted,2,0.67 [0.16-2.79],0.587114476070624
MFAP5,Microfibrillar-associated protein 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",Inverse variance weighted,2,1.43 [0.83-2.48],0.197267454118898
MFAP5,Microfibrillar-associated protein 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,Inverse variance weighted,2,0.23 [0.05-1.15],0.0739630145925469
MFAP5,Microfibrillar-associated protein 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,Inverse variance weighted,2,1.70 [0.86-3.36],0.125105869371363
MFAP5,Microfibrillar-associated protein 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,Inverse variance weighted,2,0.90 [0.62-1.30],0.570053249312668
MFAP5,Microfibrillar-associated protein 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",Inverse variance weighted,2,1.12 [0.78-1.61],0.53560524926081
MFAP5,Microfibrillar-associated protein 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,Inverse variance weighted,2,0.70 [0.28-1.75],0.440879862029133
MFAP5,Microfibrillar-associated protein 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,Inverse variance weighted,2,4.50 [1.82-11.11],0.0011020617288768
MFAP5,Microfibrillar-associated protein 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,Inverse variance weighted,2,0.72 [0.27-1.94],0.520797597968724
MFAP5,Microfibrillar-associated protein 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,Inverse variance weighted,2,1.26 [0.97-1.62],0.0807925802148071
MFAP5,Microfibrillar-associated protein 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,Inverse variance weighted,2,1.16 [0.98-1.37],0.0819437876466236
MFAP5,Microfibrillar-associated protein 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,Inverse variance weighted,2,0.72 [0.27-1.97],0.528586326631632
MFAP5,Microfibrillar-associated protein 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,Inverse variance weighted,2,1.12 [0.95-1.32],0.188619076615036
MFAP5,Microfibrillar-associated protein 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,Inverse variance weighted,2,1.41 [0.71-2.78],0.322979537693306
MFAP5,Microfibrillar-associated protein 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",Inverse variance weighted,2,1.00 [0.48-2.09],0.993799362526227
MFAP5,Microfibrillar-associated protein 5,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,Inverse variance weighted,2,1.17 [0.91-1.50],0.212697272830001
MFAP5,Microfibrillar-associated protein 5,Chapter IX Diseases of the circulatory system,Cardiac arrest,Inverse variance weighted,2,2.28 [1.07-4.89],0.0333108468268848
MFAP5,Microfibrillar-associated protein 5,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,Inverse variance weighted,2,1.20 [0.67-2.14],0.53753328899443
MFAP5,Microfibrillar-associated protein 5,Chapter IX Diseases of the circulatory system,"Heart failure, strict",Inverse variance weighted,2,0.90 [0.71-1.13],0.351846353559208
MFAP5,Microfibrillar-associated protein 5,Chapter IX Diseases of the circulatory system,Hypotension,Inverse variance weighted,2,1.51 [0.89-2.56],0.127535648915735
MFAP5,Microfibrillar-associated protein 5,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,Inverse variance weighted,2,1.26 [0.42-3.77],0.674281604939794
MFAP5,Microfibrillar-associated protein 5,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",Inverse variance weighted,2,1.22 [0.77-1.96],0.396823932028532
MFAP5,Microfibrillar-associated protein 5,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",Inverse variance weighted,2,1.58 [0.87-2.87],0.130208412050572
MFAP5,Microfibrillar-associated protein 5,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,Inverse variance weighted,2,1.60 [0.66-3.90],0.298889681655825
MFAP5,Microfibrillar-associated protein 5,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,Inverse variance weighted,2,1.36 [0.82-2.28],0.235058446377856
MFAP5,Microfibrillar-associated protein 5,Chapter X Diseases of the respiratory system,Influenza and pneumonia,Inverse variance weighted,2,1.20 [1.03-1.40],0.0227831166925518
MFAP5,Microfibrillar-associated protein 5,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,Inverse variance weighted,2,1.26 [0.90-1.77],0.171225139342709
MFAP5,Microfibrillar-associated protein 5,Chapter X Diseases of the respiratory system,Other diseases of pleura,Inverse variance weighted,2,1.14 [0.85-1.52],0.37663179607051
MFAP5,Microfibrillar-associated protein 5,Chapter X Diseases of the respiratory system,Pulmonary oedema,Inverse variance weighted,2,1.15 [0.24-5.62],0.861168239155262
MFAP5,Microfibrillar-associated protein 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,Inverse variance weighted,2,1.09 [0.73-1.62],0.668229035134882
MFAP5,Microfibrillar-associated protein 5,Chapter XIV Diseases of the genitourinary system,Acute renal failure,Inverse variance weighted,2,1.47 [0.93-2.33],0.0985533824095223
MFAP5,Microfibrillar-associated protein 5,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,Inverse variance weighted,2,1.66 [0.58-4.71],0.34489821503344
MFAP5,Microfibrillar-associated protein 5,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,Inverse variance weighted,2,1.33 [0.92-1.93],0.134337547183911
MFAP5,Microfibrillar-associated protein 5,Chapter XIV Diseases of the genitourinary system,Dialysis,Inverse variance weighted,2,1.32 [0.44-3.94],0.620271643826928
MFAP5,Microfibrillar-associated protein 5,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,Inverse variance weighted,2,1.11 [0.40-3.10],0.835423579830209
MFAP5,Microfibrillar-associated protein 5,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,Inverse variance weighted,2,0.73 [0.40-1.31],0.289210883027717
MFAP5,Microfibrillar-associated protein 5,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,Inverse variance weighted,2,0.88 [0.50-1.54],0.648582553143427
MFAP5,Microfibrillar-associated protein 5,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,Inverse variance weighted,2,0.21 [0.07-0.69],0.0095301987228936
MFAP5,Microfibrillar-associated protein 5,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,Inverse variance weighted,2,1.16 [0.96-1.40],0.121613599011728
MFAP5,Microfibrillar-associated protein 5,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,Inverse variance weighted,2,1.36 [0.68-2.71],0.380235003066638
